These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2108854)

  • 41. Tissue plasminogen activator and acute pulmonary embolism.
    Goldhaber SZ; Kessler CM; Heit J; Markis JE; Sharma GV; Dawley DL; Meyerovitz MF; Vaughan DE; Parker JA; Come PC
    J Cell Biochem; 1988 Dec; 38(4):303-12. PubMed ID: 3149283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute pulmonary embolism treated with tissue plasminogen activator.
    Goldhaber SZ; Vaughan DE; Markis JE; Selwyn AP; Meyerovitz MF; Loscalzo J; Kim DS; Kessler CM; Dawley DL; Sharma GV
    Lancet; 1986 Oct; 2(8512):886-9. PubMed ID: 2876327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Caval thrombolysis in neonates using low doses of recombinant human tissue-type plasminogen activator.
    Anderson BJ; Keeley SR; Johnson ND
    Anaesth Intensive Care; 1991 Feb; 19(1):22-7. PubMed ID: 1901463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reactivated recombinant plasminogen activator inhibitor-1 (rPAI-1) effectively prevents thrombolysis in vivo.
    Vaughan DE; Declerck PJ; Van Houtte E; De Mol M; Collen D
    Thromb Haemost; 1992 Jul; 68(1):60-3. PubMed ID: 1514173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Bolus thrombolysis in pulmonary embolism. Review of experimental and clinical data].
    Zonzin P; Roncon L; Carraro M
    Ann Ital Med Int; 1996; 11(2):132-7. PubMed ID: 8974439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis model.
    Spriggs D; Gold HK; Hashimoto Y; Van Houtte E; Vermylen J; Collen D
    Thromb Haemost; 1989 Feb; 61(1):93-6. PubMed ID: 2501892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction.
    Meneveau N; Schiele F; Vuillemenot A; Valette B; Grollier G; Bernard Y; Bassand JP
    Eur Heart J; 1997 Jul; 18(7):1141-8. PubMed ID: 9243149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Chronic effects of 100 mg/2 hours recombinant tissue-type plasminogen activator therapy regimen for patients with acute pulmonary thromboembolism].
    Li ZP; Xu B; Jiang R; Li JL; Jiang X; Sun ML; Jing ZC; Li YP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):224-8. PubMed ID: 23879948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Intraoperative thrombolysis with rt-PA in massive pulmonary embolism during venous thrombectomy].
    Scheeren TW; Hopf HB; Peters J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 Nov; 29(7):440-5. PubMed ID: 7819477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hemodynamic impact of thrombolytic therapy in acute pulmonary thromboembolism].
    Baruzzi AC; Knobel E; Cirenza C; Smith MR; Barbas CS; Fernandes Júnior CJ; Akamine N
    Arq Bras Cardiol; 1995 Jun; 64(6):515-20. PubMed ID: 8561669
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reteplase: a review of its use in the management of thrombotic occlusive disorders.
    Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
    Am J Cardiovasc Drugs; 2006; 6(4):265-85. PubMed ID: 16913828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of mobile right heart thrombi: a prospective series.
    Pierre-Justin G; Pierard LA
    Int J Cardiol; 2005 Mar; 99(3):381-8. PubMed ID: 15771917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Rt-PA thrombolysis in the treatment of massive pulmonary embolism].
    Van Hover P; Stockx L; Raat H; Vervloessem I; Vandenbosch G; Verhaeghe R; Baert AL
    J Belge Radiol; 1996 Nov; 79(5):208-10. PubMed ID: 8984107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of canine embolic pulmonary hypertension with recombinant tissue plasminogen activator. Efficacy of dosing regimes.
    Shiffman F; Ducas J; Hollett P; Israels E; Greenberg D; Cook R; Prewitt RM
    Circulation; 1988 Jul; 78(1):214-20. PubMed ID: 3133136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single bolus administration of recombinant tissue plasminogen activator: effects on infarct related vessel patency, microvascular perfusion, and microvascular reocclusion in a canine model of thrombotic occlusion/reperfusion.
    Longridge DJ; Follenfant MJ; Ford AJ
    Cardiovasc Res; 1991 Mar; 25(3):184-91. PubMed ID: 1903080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
    Collen D; Stassen JM; De Cock F
    Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcatheter thrombolysis with high-dose bolus tissue plasminogen activator in iatrogenic arterial occlusion after femoral arterial catheterization.
    Tsetis DK; Kochiadakis GE; Hatzidakis AA; Skalidis EI; Chryssou EG; Tritou IN; Vardas PE; Gourtsoyiannis NC
    Cardiovasc Intervent Radiol; 2002; 25(1):36-41. PubMed ID: 11907772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical experience with recombinant tissue plasminogen activator in the management of intracardiac and arterial thrombosis in children.
    Olgun H; Buyukavci M; Ceviz N; Sahin IO; Yildirim ZK; Colak A; Tekgunduz KS; Caner I
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):726-30. PubMed ID: 24806322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.
    Goldhaber SZ; Kessler CM; Heit J; Markis J; Sharma GV; Dawley D; Nagel JS; Meyerovitz M; Kim D; Vaughan DE
    Lancet; 1988 Aug; 2(8606):293-8. PubMed ID: 2899718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.